Antiadhesive carbohydrates

Abstract

Provided is a pharmaceutical or dietetic product, which serves for reducing and/or blocking the adhesion of pathogenic substances and organisms to eucaryontic cells, in particular mammal cells. Said preparation contains at least one carbohydrate having an uronic acid unit on one of the ends thereof. 10 to 100% of the present, terminal uronic acid units pertaining to the carbohydrates are provided with a double bond that is especially situated between the C 4 and C 5 atom.

1 - 51 . (canceled) 
     
     
         52 . A preparation comprising an anti adhesive carbohydrate or a mixture of antiadhesive carbohydrates having a terminal uronic acid unit on one of the ends thereof,
 wherein the antiadhesive carbohydrates have a maximum degree of polymerization of DP 100, 10-50% of the terminal uronic acid units of the antiadhesive carbohydrates have a double bond, and 50 to 100% of the double bonds are situated between the C 4  and C 5  atom of the terminal uronic acid units;   wherein said preparation comprises, apart from the antiadhesive carbohydrates, a prebiotic carbohydrate mixture of two different, essentially soluble carbohydrate components A and B, that remain undigested in the gastrointestinal tract and reach the large intestine non-absorbed, the carbohydrate component A is built up from at least one monosaccharide or from at least one oligosaccharide having from two to six saccharide units or from a mixture of two or several of these saccharides, the carbohydrate component B is built up from a polysaccharide having at least seven saccharide units or from a mixture of two or several polysaccharides, the carbohydrate component A=5 to 95 wt-%, the carbohydrate component B=5 to 95 wt-% of the sum of the carbohydrate components A+B, at least 80 wt-% of the carbohydrates/saccharides of the carbohydrate component A and B are prebiotically active, and the carbohydrates, which constitute the carbohydrate component A and the carbohydrate component B, do not represent the antiadhesive carbohydrates; and   wherein the preparation is a food product.   
     
     
         53 . The preparation of  claim 52 , further comprising fats, proteins, minerals, trace elements, and vitamins. 
     
     
         54 . The preparation of  claim 52 , further comprising a component selected from the group consisting of fats, proteins, minerals, trace elements, and vitamins. 
     
     
         55 . The preparation of  claim 52 , characterized in that 10 to 100% of the antiadhesive carbohydrates having a terminal uronic acid unit comprise a reducing end, and comprise the terminal uronic acid unit on another end. 
     
     
         56 . The preparation of  claim 52 , wherein said preparation contains several antiadhesive carbohydrates having a terminal uronic acid unit, which have a different degree of polymerization. 
     
     
         57 . The preparation of  claim 52 , characterized in that the antiadhesive carbohydrates have a maximum degree of polymerization DP 2 up to DP 40. 
     
     
         58 . The preparation of  claim 52 , characterized in that the content of the antiadhesive carbohydrates described in neutral sugar units is a maximum of 50%. 
     
     
         59 . A method for treatment of infections of the gastrointestinal tract, the blood system, the respiratory passages, the urogenital tract, and the nasopharyngeal meatus, or damages of the cells of the gastrointestinal tract, the blood system, the respiratory passages, the urogenital tract, and the nasopharyngeal meatus caused by toxins or heavy-metal cations, comprising administering an effective amount of the preparation of  claim 52 ,
 wherein the antiadhesive carbohydrates of said preparation are administered in a quantity of at least 8 mg/kg per day.   
     
     
         60 . The method of  claim 59 , wherein the antiadhesive carbohydrates of said preparation are administered in a quantity of 8-20 mg/kg per day.